Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
Clinical trial NCT00124527 · COMPLETED
Trial details
- NCT number
- NCT00124527
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-31
- Primary completion
- 2006-08-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.